Endra Life Sciences Inc (NDRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Operating Expenses | 3,129 | 2,995 | 2,939 | 3,313 | 3,417 |
| Operating Income | -3,129 | -2,995 | -2,939 | -3,313 | -3,417 |
| Other Income | 28 | 438 | -3 | 24 | -23 |
| Pre-tax Income | -3,101 | -2,557 | -2,943 | -3,290 | -3,440 |
| Net Income Continuous | -3,101 | -2,557 | -2,943 | -3,290 | -3,440 |
| Net Income | $-3,101 | $-2,557 | $-2,943 | $-3,290 | $-3,440 |
| EPS Basic Total Ops | -706.20 | -751.75 | -1,625.87 | -1,695.80 | -1,905.59 |
| EPS Basic Continuous Ops | -775.21 | -745.58 | -1,623.43 | -1,707.90 | -1,903.89 |
| EPS Diluted Total Ops | -706.20 | -751.75 | -1,625.87 | -1,695.80 | -1,905.59 |
| EPS Diluted Continuous Ops | -775.21 | -745.58 | -1,623.43 | -1,707.90 | -1,903.89 |
| EBITDA(a) | $-3,059 | $-2,922 | $-2,868 | $-3,246 | $-3,359 |